| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Peter Gøtzsche
|
Business associate |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2001-01-01 | N/A | Publication of a systematic review of 114 clinical trials comparing placebo recipients with untre... | Copenhagen (implied) | View |
This page from a New Yorker article discusses the nuances of the placebo effect, contrasting statistical meta-analyses by researchers like Asbjørn Hróbjartsson with the experimental work of Ted Kaptchuk. It details Kaptchuk's "open-label" placebo study on I.B.S. patients and explores the philosophical implications of placebo research in modern medicine. The text also delves into Kaptchuk's personal history as a radical activist in the 1960s and his background in Chinese medicine.
This document is a page from a December 12, 2011 issue of The New Yorker, stamped with 'HOUSE_OVERSIGHT_029929', indicating it is part of a Congressional investigation. The text is an article discussing the medical efficacy and scientific definition of the 'placebo effect,' featuring interviews with Robert Temple of the FDA and referencing studies by Danish researchers. While the content is scientific, its inclusion in the oversight file suggests it may be relevant to inquiries regarding medical funding, research practices, or specific individuals (like Epstein) who may have had interests in these scientific fields.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity